In other lymphoid hematologic malignancies such as lymphoma, MM, ALL, and CLL than AML, there could be some differences according to the percentages of both malignant cells and CD34+CD38− compartments within bone marrows because of niche competition between two cell populations. The gene discussed is CD34; the disease is cancer.